{"schema_version":"1","generated_at":"2026-11-01T15:22:54.531Z","data_as_of":"2026-10-27","url":"https://www.findmykol.com/kol/rekha-chaudhary","json_url":"https://www.findmykol.com/kol/rekha-chaudhary/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"rekha-chaudhary","name":"Rekha Chaudhary","credential":"MD","title":"Adjunct Professor, Internal Medicine, College of Medicine (University of Cincinnati)","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Neuro-Oncology","therapeutic_areas":["Neuro-Oncology","Gynecologic","Breast"],"institution":"University of Cincinnati College of Medicine","institution_url":"https://www.findmykol.com/institution/university-of-cincinnati-college-of-medicine","city":"West Chester","state":"OH","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1982699484","orcid":"0000-0002-8068-8129","openalex":"A5028848898"},"summary":"Rekha Chaudhary is Adjunct Professor, Internal Medicine, College of Medicine (University of Cincinnati) at University of Cincinnati College of Medicine. OpenAlex indexes 70 publications with 1,151 citations (h-index 13); ClinicalTrials.gov lists 3 registered studies with this person as an investigator.","overview":{"text":"Rekha Chaudhary, M.D., is Adjunct Professor, Internal Medicine, College of Medicine (University of Cincinnati) at University of Cincinnati College of Medicine. The public record shows 70 publications with 1,151 citations (h-index 13), centered on Glioma Diagnosis and Treatment, Ovarian cancer diagnosis and treatment, Cancer survivorship and care. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 11 companies.","bullets":["Most recent indexed publication: 2024 · Clinical cancer research","Top research focus: Glioma Diagnosis and Treatment","3 registered trials on ClinicalTrials.gov","Open Payments reporting from 11 companies"],"generated_at":"2026-10-31"},"focus":{"indications":[{"label":"Neuro-Oncology / Glioma","therapeutic_area":"Oncology","trials":1,"topics":1,"strength":4},{"label":"Meningioma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Neural Tube Defects","therapeutic_area":"Neurology","trials":1,"topics":0,"strength":3},{"label":"Carcinoma, Squamous Cell","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Breast Cancer","therapeutic_area":"Oncology","trials":0,"topics":1,"strength":1},{"label":"Ovarian / Gynecologic Cancer","therapeutic_area":"Oncology","trials":0,"topics":1,"strength":1}],"research_topics":["Glioma Diagnosis and Treatment","Ovarian cancer diagnosis and treatment","Cancer survivorship and care","PARP inhibition in cancer therapy","Breast Cancer Treatment Studies"],"drugs_studied":{"total":11,"shown":3,"withheld":8,"rows":[{"name":"Opdivo","generic":"Nivolumab","trials":0,"payments":21,"publications":0,"mentions":21},{"name":"Libtayo","generic":"Cemiplimab","trials":0,"payments":18,"publications":0,"mentions":18},{"name":"Kimmtrak","generic":"Tebentafusp","trials":0,"payments":2,"publications":0,"mentions":2}]},"works_with":{"total":14,"shown":3,"withheld":11,"rows":[{"name":"E.R. Squibb & Sons, L.L.C.","trials":0,"payments":38,"mentions":38},{"name":"Regeneron Healthcare Solutions, Inc.","trials":0,"payments":10,"mentions":10},{"name":"Genzyme Corporation","trials":0,"payments":8,"mentions":8}]}},"scholarship":{"works_count":70,"cited_by_count":1151,"h_index":13,"i10_index":14,"pubmed_count":1,"latest_activity_year":2025,"source":"works"},"trials":{"count":3,"shown":3,"withheld":0,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT07042295","title":"Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System","phase":"PHASE2","status":"RECRUITING","role":"Investigator","sponsor":"National Cancer Institute (NCI)","source_url":"https://clinicaltrials.gov/study/NCT07042295","trial_url":"https://www.findmykol.com/trial/NCT07042295"},{"nct":"NCT03278249","title":"Feasibility Study of Modified Atkins Ketogenic Diet in the Treatment of Newly Diagnosed Malignant Glioma","phase":"NA","status":"COMPLETED","role":"Investigator","sponsor":"University of Cincinnati","source_url":"https://clinicaltrials.gov/study/NCT03278249","trial_url":"https://www.findmykol.com/trial/NCT03278249"},{"nct":"NCT02523014","title":"Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas","phase":"PHASE2","status":"RECRUITING","role":"Investigator","sponsor":"Alliance for Clinical Trials in Oncology","source_url":"https://clinicaltrials.gov/study/NCT02523014","trial_url":"https://www.findmykol.com/trial/NCT02523014"}],"source":"trials"},"payments":{"company_count":11,"program_years":{"first":2021,"last":2025},"rows_total":17,"shown":3,"withheld":14,"rows":[{"payer":"E.R. Squibb & Sons, L.L.C.","program_year":2025,"amount_usd":8761.32,"payment_count":10,"source_url":"https://openpaymentsdata.cms.gov/search?query=1982699484"},{"payer":"Celgene Corporation","program_year":2025,"amount_usd":19.26,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1982699484"},{"payer":"E.R. Squibb & Sons, L.L.C.","program_year":2024,"amount_usd":11756.71,"payment_count":7,"source_url":"https://openpaymentsdata.cms.gov/search?query=1982699484"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1982699484","source":"payments"},"prescribing":{"data_year":2024,"areas_total":5,"areas_shown":3,"areas":[{"area":"Blood & clotting","share_pct":35,"classes_total":2,"classes":[{"class":"Factor Xa inhibitor","setting":"prescribed","share_pct":23.3,"drugs":[{"name":"Eliquis","share_pct":100}],"max_beneficiaries":null},{"class":"Vitamin K antagonist","setting":"prescribed","share_pct":11.7,"drugs":[{"name":"Warfarin Sodium","share_pct":100}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":23.3,"classes_total":2,"classes":[{"class":"Proton pump inhibitor","setting":"prescribed","share_pct":12.6,"drugs":[{"name":"Pantoprazole Sodium","share_pct":100}],"max_beneficiaries":null},{"class":"Serotonin-3 Receptor Antagonist","setting":"prescribed","share_pct":10.7,"drugs":[{"name":"Ondansetron Hcl","share_pct":100}],"max_beneficiaries":null}]},{"area":"Nervous system","share_pct":17.5,"classes_total":1,"classes":[{"class":"Other antiepileptics","setting":"prescribed","share_pct":17.5,"drugs":[{"name":"Levetiracetam","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":69.3,"facility_pct":30.7},"source":"medicare"},"funding":{"award_count":0,"rows_total":0,"shown":0,"withheld":0,"rows":[],"source":"grants"},"congress":{"count":8,"years":{"first":2012,"last":2025},"societies":["AACR","ASCO","ASTRO"],"shown":3,"withheld":5,"rows":[{"title":"Animated patient’s guide to melanoma: Assessing patient understanding, shared decision-making, and health outcomes.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2025,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2025.43.16_suppl.9581","source_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.9581","status":"verified"},{"title":"Radiation Necrosis, Pseudoprogression, and Enhancing Radiologic Changes after Photon or Proton Chemoradiotherapy for Grade 2-3 IDHmt Gliomas","society":"ASTRO","meeting":"ASTRO Annual Meeting","year":2025,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1016/j.ijrobp.2025.06.2167","source_url":"https://doi.org/10.1016/j.ijrobp.2025.06.2167","status":"verified"},{"title":"Abstract CT224: Multi-institutional randomized phase-3 trial comparing cancer stem cell-targeted vs physician-choice treatments in patients with recurrent high-grade gliomas (NCT03632135)","society":"AACR","meeting":"AACR (meeting unresolved)","year":2022,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1158/1538-7445.am2022-ct224","source_url":"https://doi.org/10.1158/1538-7445.am2022-ct224","status":"verified"}],"source":"congress"},"publications":{"total":1,"shown":1,"withheld":0,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"A Phase 0/I Pharmacokinetic and Pharmacodynamics and Safety and Tolerability Study of Letrozole in Combination with Standard Therapy in Recurrent High-Grade Gliomas.","year":2024,"journal":"Clinical cancer research : an official journal of the American Association for Cancer Research","types":["Journal Article","Clinical Trial, Phase I"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/38530160/","status":"verified"}],"most_cited":{"total":70,"shown":5,"withheld":65,"rows":[{"title":"First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma","year":2018,"cited_by_count":537,"type":"article","source_url":"https://doi.org/10.1186/s12967-018-1507-6"},{"title":"A multicenter phase II study of temozolomide plus disulfiram and copper for recurrent temozolomide-resistant glioblastoma","year":2019,"cited_by_count":120,"type":"article","source_url":"https://doi.org/10.1007/s11060-019-03125-y"},{"title":"Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations","year":2022,"cited_by_count":115,"type":"article","source_url":"https://doi.org/10.1200/jco.21.02371"},{"title":"CNS Hemangiopericytoma","year":2014,"cited_by_count":91,"type":"article","source_url":"https://doi.org/10.1097/coc.0000000000000146"},{"title":"Cancer stem cell assay-guided chemotherapy improves survival of patients with recurrent glioblastoma in a randomized trial","year":2023,"cited_by_count":45,"type":"article","source_url":"https://doi.org/10.1016/j.xcrm.2023.101025"}]},"source":"publications"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"Soma Sengupta","coauthored_works":27,"profile_url":"https://www.findmykol.com/kol/soma-sengupta"},{"name":"David R. Plas","coauthored_works":24},{"name":"Ady Kendler","coauthored_works":23,"profile_url":"https://www.findmykol.com/kol/ady-kendler"}],"source":"works"},"presence":{"mentions":{"total":1,"shown":1,"rows":[{"url":"https://med12.uc.edu/institutes/uc-neuroscience-institute/members/faculty-profile/Index/Pubs/tripatrr","platform":"other","status":"provisional"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":4,"shown":4,"rows":[{"value":"Board certified, American Board of Internal Medicine (Medical Oncology); certified 2005, recertified 2015","source_url":"https://med.uc.edu/landing-pages/faculty-profile/Index/Pubs/tripatrr","status":"verified","collected_at":"2026-10-31"},{"value":"MD, Northeastern Ohio College of Medicine","source_url":"https://med.uc.edu/landing-pages/faculty-profile/Index/Pubs/tripatrr","status":"verified","collected_at":"2026-10-31"},{"value":"Bachelor's degree, Kent State University (Integrated Life Sciences)","source_url":"https://med.uc.edu/landing-pages/faculty-profile/Index/Pubs/tripatrr","status":"verified","collected_at":"2026-10-31"},{"value":"Board certified, American Board of Internal Medicine (Hematology and Oncology)","source_url":"https://ucneuroscience.com/rekha-chaudhary/","status":"provisional","collected_at":"2026-10-31"}]},"secondary_affiliations":{"total":1,"shown":1,"rows":[{"value":"Neuro-oncologist, UC Neuroscience Institute (since 2010)","source_url":"https://ucneuroscience.com/rekha-chaudhary/","status":"verified","collected_at":"2026-10-31"}]}},"similar":[{"name":"Melissa Delbello","slug":"melissa-delbello","institution":"University of Cincinnati College of Medicine","specialty":"Child & Adolescent Psychiatry","url":"https://www.findmykol.com/kol/melissa-delbello","json_url":"https://www.findmykol.com/kol/melissa-delbello/profile.json"},{"name":"Alan Fleischer","slug":"alan-fleischer","institution":"University of Cincinnati College of Medicine","specialty":"Dermatology","url":"https://www.findmykol.com/kol/alan-fleischer","json_url":"https://www.findmykol.com/kol/alan-fleischer/profile.json"},{"name":"Caleb Adler","slug":"caleb-adler","institution":"University of Cincinnati College of Medicine","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/caleb-adler","json_url":"https://www.findmykol.com/kol/caleb-adler/profile.json"},{"name":"Ahmad Sedaghat","slug":"ahmad-sedaghat","institution":"University of Cincinnati College of Medicine","specialty":"Otolaryngology","url":"https://www.findmykol.com/kol/ahmad-sedaghat","json_url":"https://www.findmykol.com/kol/ahmad-sedaghat/profile.json"},{"name":"Guy McKhann","slug":"guy-mckhann","institution":"Emory University School of Medicine","specialty":"Neurological Surgery","url":"https://www.findmykol.com/kol/guy-mckhann","json_url":"https://www.findmykol.com/kol/guy-mckhann/profile.json"},{"name":"Patrick Wen","slug":"patrick-wen","institution":"Dana-Farber Cancer Institute","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/patrick-wen","json_url":"https://www.findmykol.com/kol/patrick-wen/profile.json"},{"name":"Minesh Mehta","slug":"minesh-mehta","institution":"Florida International University Herbert Wertheim College of Medicine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/minesh-mehta","json_url":"https://www.findmykol.com/kol/minesh-mehta/profile.json"},{"name":"Timothy Cloughesy","slug":"timothy-cloughesy","institution":"Ronald Reagan UCLA Medical Center","specialty":"Neurology","url":"https://www.findmykol.com/kol/timothy-cloughesy","json_url":"https://www.findmykol.com/kol/timothy-cloughesy/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":14,"congress":5,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-10-31"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-10-31"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 to 2025","collected_at":"2026-10-31"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-10-31"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-10-31"}},"methodology_url":"https://www.findmykol.com/about#methodology"}